Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy
Titel:
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy
Auteur:
Rajkumar, Shivshankari Berry, Diana Heney, Kayla A. Strong, Colton Ramsay, LeeAnn Lajoie, Mathieu Alkallas, Rached Nguyen, Tan-Trieu Thomson, Cameron Ahanfeshar-Adams, Mozhdeh Dankner, Matthew Petrella, Teresa Rose, April A.N. Siegel, Peter M. Watson, Ian R.